Kritische 8-K Meldungen
HOCH Abgang Schlüsselpersonen (13.03.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 13.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(e) Compensatory Arrangements of Certain Officers On March 11, 2026, Earth Science Tech, Inc., a |
| 19.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(e) Compensatory Arrangements of Certain Officers On March 11, 2025, the Board of Directors and C |
| 30.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(d) Election of Directors On December 26, 2024, a majority of shareholders of Earth Science Tech, I |
| 27.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(e) Compensatory Arrangements of Certain Officers On August 15, 2024, the Board of Directors of Ear |
| 19.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 15.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 05.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(b) Departure of Directors Certain Officers On March 3, 2024, Earth Science Tech, Inc., a Florida c |
| 21.02.2024 | Item 4.02 — Bilanzkorrekturen | EXTREM | SEC | Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit or Completed Interim Revie |
| 16.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(a) Departure of Directors or Certain Officers On August 14, 2023, Earth Science Tech, Inc. (the “Com |
| 17.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(b) Departure of Directors or Certain Officers On July 15, 2023, Wendell Hecker resigned from his rol |
Stammdaten
Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. Its products include hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs through its retail store, clinics, pharmacies, as well as through online. It also provides medical equipment and devices. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. The company was incorporated in 2010 and is headquartered in Doral, Florida.
Unternehmen & Branche
| Name | Earth Science Tech, Inc. |
|---|---|
| Ticker | ETST |
| CIK | 0001538495 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 40,8 Mio. USD |
| Beta | 2,09 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | 8,386,779 | 910,376 | 0.00 | 8,089,437 | |
| 2025-09-30 | 10-Q | 9,050,626 | 966,823 | 0.00 | 8,667,416 | |
| 2025-06-30 | 10-Q | 8,760,190 | 465,039 | 0.00 | 7,779,453 | |
| 2025-03-31 | 10-K | 33,117,624 | 3,253,635 | 0.01 | 7,066,721 | 3,851,111 |
| 2024-12-31 | 10-Q | 7,352,635 | 206,411 | 0.00 | 5,708,014 | 3,280,447 |
| 2024-09-30 | 10-Q | 8,519,047 | 798,368 | 0.00 | 5,049,628 | 3,201,132 |
| 2024-06-30 | 10-Q | 8,568,918 | 1,076,254 | 0.00 | 4,772,247 | 3,167,086 |
| 2024-03-31 | 10-K | 11,953,635 | 812,139 | 0.00 | 3,881,336 | 2,249,305 |
| 2023-12-31 | 10-Q | 3,790,112 | 225,443 | 0.00 | 3,283,924 | 2,197,652 |
| 2023-09-30 | 10-Q | 1,927,720 | 444,581 | 0.00 | 3,079,613 | 1,971,909 |
| 2023-06-30 | 10-Q | 219,934 | -35,596 | 0.00 | 2,945,143 | 1,527,328 |
| 2023-03-31 | 10-K | 48,537 | -365,405 | 0.00 | 2,727,971 | 1,119,535 |
| 2022-12-31 | 10-Q | 2,533 | 98,464 | 537,376 | -900,567 | |
| 2022-09-30 | 10-Q | -73,678 | 355,762 | -2,027,573 | ||
| 2022-06-30 | 10-Q | -154,682 | 320,323 | -1,960,095 | ||
| 2022-03-31 | 10-K | 14,123 | 3,173,260 | 76,942 | -1,805,413 | |
| 2022-03-31 | 10-Q | -30,681 | 76,942 | -1,805,413 | ||
| 2021-12-31 | 10-Q | 3,997 | -115,048 | 25,680 | -1,784,732 | |
| 2021-09-30 | 10-Q | 2,455 | 3,341,399 | 53,525 | -1,679,684 | |
| 2021-06-30 | 10-Q | 7,490 | -22,410 | 38,998 | -5,021,083 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-07-22 | Saumat Giorgio R. | Director, Officer, 10% Owner, CEO | Open Market Purchase | 50,000 | 0.21 | 10,250.00 | +148,4% | |
| 2025-07-21 | Saumat Giorgio R. | Director, Officer, 10% Owner, CEO | Open Market Purchase | 100,000 | 0.20 | 20,000.00 | +289,6% | |
| 2025-07-09 | Sanchez Yovan Arturo | Director | Open Market Purchase | 20,459 | 0.18 | 3,680.57 | +53,3% | |
| 2025-07-09 | Sanchez Yovan Arturo | Director | Open Market Purchase | 1,349 | 0.18 | 236.08 | +3,4% | |
| 2025-07-09 | Sanchez Yovan Arturo | Director | Open Market Purchase | 131 | 0.18 | 23.57 | +0,3% | |
| 2025-07-08 | Sanchez Yovan Arturo | Director | Open Market Purchase | 11,105 | 0.18 | 1,997.79 | +28,9% | |
| 2025-07-02 | Sanchez Yovan Arturo | Director | Open Market Purchase | 60,805 | 0.20 | 12,161.00 | +176,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.